US OKs new use for Eli Lilly’s COVID-19 treatment

By: |
September 17, 2021 9:12 AM

The Food and Drug Administration on Thursday granted emergency use of the drug for adults and children older than 12 who may have an infection and are at high-risk for getting severe COVID-19.

Eli LillyAntibody drugs are one of the only treatments proven to reduce the risk of death from COVID-19, especially for people who are not yet in the hospital. (Photo source: Reuters)

US health officials have authorised Eli Lilly’s COVID-19 treatment for a new use in preventing disease in people who have been recently exposed to the virus.

The Food and Drug Administration on Thursday granted emergency use of the drug for adults and children older than 12 who may have an infection and are at high-risk for getting severe COVID-19. Previously the drug was authorized for high-risk patients with confirmed COVID-19. Earlier this summer the FDA authorised preventative use for a similar antibody drug from competitor Regeneron Pharmaceuticals.

Antibody drugs are one of the only treatments proven to reduce the risk of death from COVID-19, especially for people who are not yet in the hospital. Demand for the drugs has boomed as the delta variant sends cases surging again across the U.S. Federal officials have reported a 20-fold increase in orders for the drugs since mid-July.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1COVID-19: Kerala logs 9,445 new cases, 622 deaths
2COVID-19 virus test results may vary based on time of day: Study
3Merck agrees to let other drug makers make its COVID pill